These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33470435)
1. Does Bordetella pertussis vaccine offer any cross-protection against Bordetella bronchiseptica? Implications for pet owners with cystic fibrosis. Moore JE; Rendall JC; Millar BC J Clin Pharm Ther; 2021 Oct; 46(5):1194-1198. PubMed ID: 33470435 [TBL] [Abstract][Full Text] [Related]
2. A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs. Moore JE; Rendall JC; Millar BC J Clin Pharm Ther; 2022 Feb; 47(2):139-145. PubMed ID: 34328230 [TBL] [Abstract][Full Text] [Related]
3. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice. Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407 [TBL] [Abstract][Full Text] [Related]
4. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines. Sukumar N; Sloan GP; Conover MS; Love CF; Mattoo S; Kock ND; Deora R Infect Immun; 2010 May; 78(5):2008-16. PubMed ID: 20176797 [TBL] [Abstract][Full Text] [Related]
5. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642 [TBL] [Abstract][Full Text] [Related]
6. Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point. Pagliaccia C; Manetti R; Rappuoli R Arch Microbiol; 1997 Nov; 168(5):437-40. PubMed ID: 9325433 [TBL] [Abstract][Full Text] [Related]
7. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization. Hausman SZ; Burns DL Infect Immun; 2000 Jun; 68(6):3763-7. PubMed ID: 10816544 [TBL] [Abstract][Full Text] [Related]
8. Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein. Keil DJ; Burns EH; Kisker WR; Bemis D; Fenwick B Vaccine; 1999 Dec; 18(9-10):860-7. PubMed ID: 10580199 [TBL] [Abstract][Full Text] [Related]
9. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model. Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777 [TBL] [Abstract][Full Text] [Related]
10. Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. Goebel EM; Zhang X; Harvill ET PLoS One; 2009 Aug; 4(8):e6778. PubMed ID: 19707559 [TBL] [Abstract][Full Text] [Related]
11. Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection. Julio SM; Inatsuka CS; Mazar J; Dieterich C; Relman DA; Cotter PA Mol Microbiol; 2009 Mar; 71(6):1574-90. PubMed ID: 19220744 [TBL] [Abstract][Full Text] [Related]
12. Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential. Scheller EV; Cotter PA Pathog Dis; 2015 Nov; 73(8):ftv079. PubMed ID: 26416077 [TBL] [Abstract][Full Text] [Related]
13. Cross protection studies on Bordetella bronchiseptica in mice using an intracerebral challenge model. Lendvai N; Magyar T; Semjén G Vet Microbiol; 1992 Jun; 31(2-3):191-6. PubMed ID: 1626369 [TBL] [Abstract][Full Text] [Related]
14. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. Stevenson A; Roberts M FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115 [TBL] [Abstract][Full Text] [Related]
15. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898 [TBL] [Abstract][Full Text] [Related]
17. Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine. Kubler-Kielb J; Vinogradov E; Lagergård T; Ginzberg A; King JD; Preston A; Maskell DJ; Pozsgay V; Keith JM; Robbins JB; Schneerson R Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4087-92. PubMed ID: 21367691 [TBL] [Abstract][Full Text] [Related]
18. Miguelena Chamorro B; De Luca K; Swaminathan G; Longet S; Mundt E; Paul S Clin Microbiol Rev; 2023 Sep; 36(3):e0016422. PubMed ID: 37306571 [No Abstract] [Full Text] [Related]
19. Engineering bacterial toxin for the development of new vaccine against pertussis. Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870 [TBL] [Abstract][Full Text] [Related]